Connect with us

News

NAFDAC Alerts Public On Dangerous Dove Soap, Illegal Drug Products

Published

on

NAFDAC Alerts Public On Dangerous Dove Soap, Illegal Drug Products

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued public warnings regarding a popular bar soap and several drug products deemed harmful.

These warnings follow alerts from the countries where the products were manufactured.

In a series of posts on its X account on Monday, NAFDAC cautioned Nigerians against using “Dove Beauty Cream Bar Soap” and various unregistered drug products from the Philippines.

The agency stated that the soap contains chemicals dangerous to human reproductive organs, unborn children, and skin health.

NAFDAC revealed that the affected Dove soap, manufactured in Germany, has the batch number 81832M 08 and contains Butylphenyl Methylpropional (BMHCA), a substance banned in cosmetic products by the European Union due to its health risks.

The soap has since been recalled by German authorities.

Additionally, NAFDAC listed other Dove products recalled in various countries and warned Nigerians to avoid them. 

“The product does not comply with the Cosmetic Products Regulation as it is said to contain Butylphenyl Methylpropional (BMHCA), which is prohibited in cosmetic products due to its risk of harming the reproductive system, causing harm to the health of an unborn child and may cause skin sensitisation. As a result, a ban on the marketing of the product has been placed by some regulatory and public authorities, in the EU,” the agency said in a statement.

The agency also flagged 13 unregistered drug products from the Philippines, cautioning against their import, sale, or use in Nigeria.

The Philippines Food and Drug Administration had previously warned that these drugs have not undergone the proper registration process and pose potential health risks.

NAFDAC pointed out the dangers of using unregistered or falsified drug products, urging importers, distributors, and healthcare providers to remain vigilant.

The agency called on consumers to report any adverse drug reactions or suspicions to the nearest NAFDAC office or through its official channels.